SYNOPSIS Five foeto-placental function tests were studied in parallel in normal and abnormal late pregnancies with a view to establishing which test or tests is most satisfactorily able to identify the mother whose foetus is in danger.
Applying organic chemical analysis, Brown, in 1955 , succeeded in producing the first practical and objective test of early foeto-placental dysfunction-the daily urine oestrogen output. Since that time several other clinical chemistry techniques have been developed for the measurement and monitoring of placental function. Urine pregnanediol excretion was one of these early tests. Even though known to be normal in many cases of intrauterine death, pregnanediol assays have only comparatively recently lost favour among some obstetricians. Tests employing blood rather than 24-hr urine collections would seem to have obvious advantages if they are to provide a quick warning or confirmation that the foetus may be in danger. In the present study we looked at the reliability of blood analyses for four substances1-placental phosphatase isoenzyme and cystine aminopeptidase (oxytocinase), placental lactogen (chorionic somatomammotrophin), and oestriol-17fl. Total oestrogen excretion was also measured. Comparative data were collected for both normal and complicated terminal pregnancies. All results were correlated with the subsequent conditions "Non-standard abbreviations: h-PL = human placental lactogen; E3 = oestra-1,3,5 (lO)-triene-3, 166a, 170-triol; PA P'ase = placental alkaline phosphatase; CAS = cystine amino peptidase (nomenclature recommended by the International Union of Biochemistry, J. clin. Path. (1971) 24, 656) . Received for publication 19 February 1973. of the foetus and placenta in order to evaluate the predictive efficacy of the various tests.
Patients
Women attending antenatal afternoon clinics at two district hospitals volunteered to make part of this study possible. Fifty-one women were selected on grounds of convenience (local residence, etc). Each donated blood and 24-hr urine specimens before and after delivery. Between four and 10 blood and urine specimens were collected at weekly intervals to term and two or three specimens at two-weekly intervals after delivery.
Of the group studied, 49 produced healthy babies, one delivered a pale infant, unusually shocked at birth (Apgar score 2.2.2.6.8). However, the birth and placental weight were normal and the child subsequently thrived. There had been gross congenital abnormalities in a previous delivery. Another woman's infant died eight hours after birth, probably due to the respiratory distress syndrome. The All 24-hr urine specimens were analysed for creatinine and total oestrogens and a 10 ml aliquot was stored at -28°C for repeat analyses. During the first year of this study the method of Brown, MacLeod, Macnaughtan, Smith, and Smyth (1968) was used. Later analyses were made by the method of Oakey, Bradshaw, Eccles, Stitch, and Hayes (1967) . All blood specimens were centrifuged after 30-40 min, separated, and the serum re-centrifuged. Cell-free sera were stored in plastic pots at -28°C until analysed.
Before determining placental alkaline phosphatase an aliquot of each thawed and well mixed serum was heated in a stoppered tube at 590C ± 10C for exactly 30 min. Subsequently, the phosphatase isoenzyme activity was measured at pH 10-1 by the method of Kind and King (1954) .
Serum placental lactogen was determined in duplicate by radioimmunoanalysis using the reagents and technique supplied by Pharmacia. The procedure is based on that of Letchworth, Boardman, Bristow, Landon, and Chard (1971) . Preliminary experiments had shown the results obtained to be comparable though slightly lower than those found using reagents from the Radiochemical Centre, Amersham.
Serum cystine aminopeptidase activity was measured by a modification of the method of Tovey (1969) and recently reported in summary (Watson and Gibbard, 1973) . Kinetic measurement of the enzyme is made using Pye Unicam automation equipment AC 60/61 SP 1800 and recorder AR 25.
Serum (100 ,ul) is mixed with 1-0 ml of buffer at pH 7-0 (50 mM KH2PO4-NaOH) and 100 ,lI of substrate (6-0 mmol, S-benzyl L-cysteine-4' nitroanilide per litre of 2-methoxyethanol) is added. The reaction rate if followed graphically over a two minperiod beginning one min after the addition of substrate. Increase in absorbance due to p-nitroaniline liberation is measured at 405 nm. The reaction temperature is 300C. One Mild foeto-placental dysfunction was apparent , and 179 (77-413) ng/ml. in eight pregnancies, but of these, only one (Jh) showed definite laboratory evidence of abnormality before delivery; tests giving abnormally low results were serum PAP'ase and oestriol and urine oestriol during the period three to six weeks before delivery. The other tests were normal (table III, V) .
Of the four cases where foeto-placental dysfunction was more severe, one (Od) showed abnormality in all five tests. Another (Fj) showed low values for serum oestriol doubtful h-PL values, with the other tests normal. The mother (Sw) of the non-surviving infant presented abnormally low figures for the urine oestriol output, serum oestriol, and placental A P'ase, the other tests being normal. In the remaining case (Fm) the only test abnormality found was in the serial serum oestriol levels. These results are shown in tables III-V and figure 2. The degree of correlation between the serum and the urine oestriol values was r = 0-387 for the normal and r = 0-484 for the abnormal pregnancies ( fig. 3 ).
Discussion
The value of a biochemical test in late pregnancy lies in its ability to select for special attention the mother whose foetus is in jeopardy. In this series the serum cystine aminopeptidase (CAS) and the placental A P'ase were the least frequent forecasters of foetoplacental insufficiency. The serum PAP'ase provided warning in two cases and the CAS in only one of 12 'abnormal' pregnancies. The positive correlation found between the levels of these substances was not unexpected in view of their common origin of synthesis in the syncytiotrophoblast. However, the wide range of values found for each of the two enzymes in normal terminal pregnancy makes their discriminative use difficult in practice. For example, the term values for CAS were arithmetically distributed in the range 60-240 lU/l (and similarly for serum PAP'ase at exactly half this level). If one puts the lower CAS limit at 70 IU, this will exclude 10% of the normal pregnancies and bring only one more of the cases with placental infarction into the 'abnormal' category. We considered using a temporary fall in serum activity (in excess of analytical variation) as the indicator of abnormality, but this proved unsatisfactory in its discriminative capacity (see tables III and IV). Thus we have no reason to doubt an earlier finding (Watson, Weston, and Porter, 1965) that the plasma placental A P'ase activity is a poor indicator of placental dysfunction. The other enzyme studied (CAS) proved to be of no prognostic value.
A similar impression emerges when serum h-PL levels are considered, viz, only one of 12motherswith foeto-placental dysfunction had h-PL values below the lower limit of 3 ,g/ml during the five weeks before term (table II) . This finding was disappointing in view of the greater test sensitivity reported by others (Saxena, Emerson, and Selenkow, 1969; Keller, Baertschi, Bader, Gerber, Schmid, Saltermann, and Kopper, 1971) . However, Josimovich, Kosor, Boccella, Mintz, and Hutchinson (1970) abnormal values in any of the tests studied. There cental inadequacy; r = 0-484: n = 43, P < 0 001. would seem to be a pressing need for a more definitive laboratory test of foetal well-being. Seven of the eight mild-moderate foeto-placental dysfunction cases had serum oestriol levels within the normal range (fig 2) . The exception (Jh) showed abnormally low serum and urine oestriol levels at 34-37 weeks, becoming low normal before caesarian section for placenta praevia at 39 weeks. Each of the four patients with more severe foeto-placental dysfunction presented serum oestriol levels at or below -2SD from the relevant normal mean. However, one of the patients (Sw) at three days before delivery showed a low normal serum E3 level following the previous week's subnormal value. The corresponding urine levels were all subnormal. In another (Fj) a normal excretion of 'oestriol' was 
